Clene Inc. (CLNN) Stock Analysis

Clene Inc. (CLNN) is a publicly traded company in the CONSUMER DEFENSIVE sector. It trades at $5.87, carries a market capitalization of $83.83M. This page summarizes the public market data, fundamentals, and frequently asked questions for CLNN, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: CONSUMER DEFENSIVE - PACKAGED FOODS

Exchange: NASDAQ

Key Metrics

• Price: $5.87
• Market Cap: $83.83M
• EPS: $-3.25
• 52-Week High: $13.50
• 52-Week Low: $3.25

Market Sentiment

Clene Inc. currently has a Bullish sentiment score of 0.16.

About Clene Inc.

Clene Inc. is an innovative clinical-stage pharmaceutical firm headquartered in Salt Lake City, Utah, specializing in the development of clean-surface nanotechnology (CSN) therapies intended to address neurodegenerative diseases and other critical health conditions. With a strong emphasis on rigorous clinical trials, Clene is focused on achieving regulatory approvals for its advanced product pipeline, which positions the company as a potential leader in transforming treatment options within t...

GNG Research Analysis

GNG Research scores Clene Inc. (CLNN) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CLNN.

Frequently Asked Questions

Does CLNN pay dividends?

Clene Inc. (CLNN) does not currently pay a regular dividend.

What is CLNN's market cap?

Clene Inc. (CLNN) has a market capitalization of $83.83M with a current stock price of $5.87.